NCT06361329View on ClinicalTrials.gov

Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL

PHASE3RecruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2027

Conditions
ETP-ALL
Interventions
DRUG

Homoharringtonine

Intravenous infusion

DRUG

venetoclax

Orally by mouth

DRUG

Cytarabine

subcutaneous injection or Intravenous infusion

DRUG

G-CSF

subcutaneous injection

DRUG

Vindesine

Intravenous infusion

DRUG

Daunorubicin

Intravenous infusion

DRUG

cyclophosphamide

Intravenous infusion

DRUG

Dexamethasone

Intravenous infusion or orally

DRUG

L-ASP

subcutaneous injection

Trial Locations (1)

310003

RECRUITING

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER